share_log

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

4：持股變動聲明-高管 Sragovicz Adam
美股SEC公告 ·  05/16 10:26
牛牛AI助理已提取核心訊息
Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Adam Sragovicz, the Chief Financial Officer of Conduit Pharmaceuticals, has initiated the disposal of 74,545 Restricted Stock Units (RSUs) on May 15, 2024. The transaction is currently in progress and involves the company's common stock. The RSUs were disposed of at no cost, and following the transaction, Sragovicz will hold zero shares in the company. This move could potentially signal changes within the company's financial leadership or strategy.
Conduit Pharmicals首席財務官亞當·斯拉戈維奇已於2024年5月15日開始處置74,545個限制性股票單位（RSU）。該交易目前正在進行中，涉及該公司的普通股。限制性股票單位已免費出售，交易完成後，Sragovicz將持有該公司的零股份。此舉可能預示着公司財務領導層或戰略的變化。
Conduit Pharmicals首席財務官亞當·斯拉戈維奇已於2024年5月15日開始處置74,545個限制性股票單位（RSU）。該交易目前正在進行中，涉及該公司的普通股。限制性股票單位已免費出售，交易完成後，Sragovicz將持有該公司的零股份。此舉可能預示着公司財務領導層或戰略的變化。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。